作者:Jeffrey W. Lockman、Matthew D. Reeder、Rosann Robinson、Patricia A. Ormonde、Daniel M. Cimbora、Brandi L. Williams、J. Adam Willardsen
DOI:10.1016/j.bmcl.2011.01.077
日期:2011.3
Several series of oxindole analogues were synthesized and screened for inhibitory activity against transforming growth factor-beta-activating kinase 1 (TAK1). Modifications around several regions of the lead molecules were made, with a distal hydroxyl group in the D region being critical for activity. The most potent compound 10 shows an IC50 of 8.9 nM against TAK1 in a biochemical enzyme assay, with compounds 3 and 6 showing low micromolar cellular inhibition. (C) 2011 Elsevier Ltd. All rights reserved.